Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep384 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Regulation of glycemia in patients with type 2 diabetes with oral antidiabetics, insulin and combination therapy

Bačun Tatjana , Damjanović Ana , Lekić Ivan , Šojat Dunja , Pirić Marko

Aim of the study: The objectives of this study were to determine the regulation of glycemia (measured by fasting glucose levels and HbA1c) in patients with type 2 diabetes and to examine whether there is a difference in therapy (oral antidiabetics, insulin, combination), age, sex and BMI.Study design: Cross-sectional research with historical data.Patients: The study included 102 patients of both sexes (56% women and 44% men) with a...

ea0081ep884 | Reproductive and Developmental Endocrinology | ECE2022

Obese patients with PCOS and prediabetes: two years follow up of the effects of metformin, pioglitazone and empagliflozin treatment on metabolic control, hormonal imbalance and ovulations

Ilic Nevena , Pasquali Corrado , Culafic-Vojinovic Violeta , Eror Tatjana , Zivkovic Stanislava

Introduction: The role of metformin in PCOS is very well known and several studies reported effects of thiazolidinediones and SGLT2 inhibitors on metabolic parametars in these patients.Objective: The aim of this study was to compare the effects of metformin, pioglitazone and empagliflozin treatment on metabolic control, hormonal imbalance, weight loss and ovulations in obese patients with PCOS and prediabetes.Methods: BMI, waist ci...

ea0090ep260 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Relation of HLA system genes in patients with type 1 diabetes and other autoimmune diseases

Lekić Ivan , Marušić Romana , Marczi Saška , Bačun Tatjana

Background: Type 1 diabetes mellitus (T1DM) is caused by destruction of pancreatic beta cells. Children and adolescents with type 1 diabetes have an increased risk of developing other autoimmune diseases, most commonly autoimmune thyroiditis and celiac disease.Objectives: To examine the frequency of individual human leukocyte antigen (HLA) alleles in people with T1DM and associated autoimmune (AI) diseases of the thyroid, digestive system, and skin, and ...

ea0090ep373 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Lipid profile of postmenopausal women

Šojat Dunja , Ormanac Klara , Marušić Romana , Bačun Tatjana

Aim of the Study: The main objectives were to examine the incidence of hyperlipoproteinemia in postmenopausal women and to determine the differences in lipid profile considering age, duration of menopause and body mass index in postmenopausal women.Material and Methods: The research was structured as a cross-sectional research with historical data. The research used data collected during regular check-ups in primary health care clinics in the Osijek Heal...

ea0090ep890 | Pituitary and Neuroendocrinology | ECE2023

Case report of a patient with paraganglioma diagnosed after surgery

Cheshlaroska Markushoska Katerina , Milenkovic Tatjana , Cheshlaroska Hristina , Bilaloglu Jovanoska Belma , Tafa Arta

Introduction: Paraganglioma is a tumour derived from extra-adrenal chromaffin cells of the sympathetic paravertebral ganglia of the thorax, abdomen and pelvis. About 36 % to 60 % of the paragangliomas are functional secreting norepinephrine and normetanephrine, which cause hypertension. Non-functional paragangliomas can produce Chromogranin A. Paragangliomas also arise from the parasympathetic ganglia located along the glossopharyngeal and vagal nerves in the neck and at the b...

ea0064036 | Medullary thyroid carcinoma in two patients with neurofibromatosis type 1 | BES2019

Medullary thyroid carcinoma in two patients with neurofibromatosis type 1

Emily Pollet , Broes Martens , Helena Van Haecke , Tatjana Sajevets , Annick Van den Bruel

Introduction: Neurofibromatosis type 1 (NF1) is an autosomal dominant neurocutaneous disorder characterised by the appearance of multiple, mostly benign, tumours throughout the skin and central nervous system. Furthermore, NF1 is associated with a number of (pre)malignant tumours including pheochromocytoma, glioma, invasive breast cancer and (pre)malignant peripheral nerve sheath tumours (1). Approximately 1:2500 to 1:3500 individuals are affected.Medull...

ea0063p635 | Interdisciplinary Endocrinology 1 | ECE2019

Hypothyroidism and Down syndrome

Kavecan Ivana , Privrodski Jadranka Jovanovic , Obrenovic Milan , Privrodski Boris , Mudrinic Tatjana Redzek

Background and Aims: Individuals with Down syndrome have an increased risk of developing hypothyroidism, autoimmune etiology. Prevalence of hypothyroidism in Down syndrome people is from 15% to 65%. Congenital hypothyroidism is about 25 times more common among newborns and infants with Down syndrome in comparison with the general population with incidence of 0.7% permanent cases and 0.3% transient congenital hypothyroidism cases, detected by newborn screening. Beyond the newbo...

ea0049ep154 | Endocrine tumours and neoplasia | ECE2017

Development of an everolimus-resistant BON1 cell line with altered cell cycle and c-Met activity

Prada Elke Tatjana Aristizabal , Maurer Julian , Spottl Gerald , Auernhammer Christoph , Nolting Svenja

Introduction: Pancreatic neuroendocrine tumors (panNETs) are often inoperable at diagnosis. The mTORC1 inhibitor everolimus is approved for the treatment of advanced NETs. Unfortunately, the development of resistance against everolimus limits its clinical efficacy.Aim: Our aim was to establish an everolimus-resistant panNET cell line to find common mechanisms of resistance.Methods: Pancreatic neuroendocrine tumor cells (BON1) were ...

ea0044p156 | Neuroendocrinology and pituitary | SFEBES2016

The role of the microenvironment in the invasive phenotype of familial pituitary tumours

Barry Sayka , Carlsen Eivind , Gadaleta Emanuela , Berney Dan , Chelala Claude , Crnogorac-Jurcevic Tatjana , Korbonits Marta

Background: Patients with heterozygote germline mutations in the aryl-hydrocarbon receptor interacting protein (AIP) gene (AIPpos) develop often aggressively growing tumours in early teenage years. The mechanism of this behaviour is not clear.Aim: The role of the microenvironment in the invasive phenotype of AIPpos pituitary tumours.Methods and results: We established that AIPpos GH-secreting tumours are infiltrated by a large numb...

ea0041ep729 | Neuroendocrinology | ECE2016

The cyclin-dependent kinase 4/6 inhibitor LEE001 (ribuciclib) demonstrates antiproliferative effects in neuroendocrine tumor cells in vitro

Prada Elke Tatjana Aristizabal , Nolting Svenja , Spottl Gerald , Maurer Julian , Auernhammer Christoph

Cyclin-dependent kinases (CDKs) are crucial for the cell cycle regulation and alterations of the cell cycle and its regulators are often observed in human malignancies. CDK4/6 in particular orchestrates the G1 phase progression and the G1/S transition. Here we investigated the in vitro effects of the CDK4/6 inhibitor LEE001(Novartis, Basel) on the human neuroendocrine tumor (NET) cell lines BON1, QGP1 and NCI-H727. The cells were treated with different concentrations ...